Living donor liver transplantation in patients who have received pretransplant treatment for hepatocellular carcinoma

Transplantation

Volumn 91, Issue 8, 2011, Pages

  Yoshizumi, Tomoharu ^a   Shirabe, Ken ^a   Soejima, Yuji ^a   Taketomi, Akinobu ^a   Ikegami, Toru ^a   Uchiyama, Hideaki ^a   Harada, Noboru ^a   Ijichi, Hideki ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DECARBOXYPROTHROMBIN;

CANCER RECURRENCE; CANCER SIZE; CHEMOEMBOLIZATION; HEPATITIS C; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; MICROWAVE THERAPY; MORTALITY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENCE RISK; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79954617439     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318210de92     Document Type: Letter

References (8)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907.
2. Belghiti J. Resection and liver transplantation for HCC. J Gastroenterol 2009; 44(suppl 19): 132.
3. Poon RT, Fan ST, Lo CM, et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: Implications for a strategy of salvage transplantation. Ann Surg 2002; 235: 373.
4. Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: A retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35.
5. Taketomi A, Sanefuji K, Soejima Y, et al. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation 2009; 87: 531.
6. Soejima Y, Taketomi A, Yoshizumi T, et al. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation 2007; 83: 893.
7. Eguchi S, Hidaka M, Tomonaga T, et al. Actual therapeutic efficacy of pre-transplant treatment on hepatocellular carcinoma and its impact on survival after salvage living donor liver transplantation. J Gastroenterol 2009; 44: 624.
8. Shirabe K, Itoh S, Yoshizumi T, et al. The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 2007; 95: 235.